| The mechanisms of action of valproate in neuropsychiatric disorders: can we see the forest for the trees? G Rosenberg Cellular and Molecular Life Sciences 64 (16), 2090-2103, 2007 | 370 | 2007 |
| DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischaemic stroke HC Diener, D Schneider, Y Lampl, NM Bornstein, A Kozak, G Rosenberg International Journal of Stroke 3, 441, 2008 | 71 | 2008 |
| DP-b99, a membrane-activated metal ion chelator, as neuroprotective therapy in ischemic stroke HC Diener, D Schneider, Y Lampl, NM Bornstein, A Kozak, G Rosenberg Stroke, 2008 | 71 | 2008 |
| Metal ion chelation in neurodegenerative disorders I Angel, A Bar, T Horovitz, G Taler, M Krakovsky, D Resnitsky, ... Drug development research 56 (3), 300-309, 2002 | 59 | 2002 |
| Results of membrane-activated chelator stroke intervention randomized trial of DP-b99 in acute ischemic stroke KR Lees, N Bornstein, HC Diener, PB Gorelick, G Rosenberg, A Shuaib Stroke, 2013 | 41 | 2013 |
| The Membrane-Activated Chelator Stroke Intervention (MACSI) Trial of DP-b99 in acute ischemic stroke: a randomized, double-blind, placebo-controlled, multinational pivotal … G Rosenberg, N Bornstein, HC Diener, PB Gorelick, A Shuaib, K Lees, ... International Journal of Stroke 6 (4), 362-367, 2011 | 33 | 2011 |
| A Novel Phospholipid Derivative of Indomethacin, DP-155 [Mixture of 1-Steroyl and 1-Palmitoyl-2-{6-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido] hexanoyl}-sn … E Dvir, JE Friedman, JY Lee, JY Koh, F Younis, S Raz, I Shapiro, ... Journal of Pharmacology and Experimental Therapeutics 318 (3), 1248-1256, 2006 | 32* | 2006 |
| Clinical pharmacology of DP‐b99 in healthy volunteers: First administration to humans G Rosenberg, I Angel, A Kozak British journal of clinical pharmacology 60 (1), 7-16, 2005 | 26 | 2005 |
| Transient immunosuppression: a bridge between infection and the atypical autoimmunity of Guillain–Barré syndrome? I Steiner, G Rosenberg, I Wirguin Clinical & Experimental Immunology 162 (1), 32-40, 2010 | 14 | 2010 |
| Clobetasol 17-propionate cream as an effective preventive treatment for drug induced superficial thrombophlebitis E Dvir, S Russo, A Meshorer, R Duvdevani, G Rosenberg Scand. J. Lab. Anim. Sci 36 (2), 123-130, 2009 | 9 | 2009 |
| Evaluation of safety and changes in the NIH Stroke Scale, Rankin, and Barthel scores following DP-b99 administration to acute stroke patients G Rosenberg, I Angel, A Kozak, D Schneider Stroke 35 (1), 338-338, 2004 | 7 | 2004 |
| The impact of R353Q genetic polymorphism in coagulation factor VII on the initial anticoagulant effect exerted by warfarin C Shaul, S Blotnick, L Deutsch, G Rosenberg, Y Caraco European Journal of Clinical Pharmacology 75, 343-350, 2019 | 5 | 2019 |
| Methylphenidate therapy, headaches and caffeine consumption B Musafia, G Rosenberg Journal of clinical psychopharmacology 33 (1), 148, 2013 | 4 | 2013 |
| A comparative crossover evaluation of amlodipine and nifedipine GITS before and after a missed dose: 48-h blood pressure profiles N Nussinovitch, G Rosenberg, E Peleg, T Rosenthal American journal of hypertension 15 (6), 580-582, 2002 | 4 | 2002 |
| The Neuroprotective Agent DP‐b99 Does Not Interact with S‐warfarin In Vivo Despite Significant CYP2C9 Inhibition In Vitro G Rosenberg, LS Marshall, Y Caraco Basic & clinical pharmacology & toxicology 108 (4), 289-292, 2011 | 3 | 2011 |
| And why not thrombolysis in the ambulance (at least for some)? G Rosenberg, I Steiner Neurology 87 (2), 214-219, 2016 | 2 | 2016 |
| Reversion from mild cognitive impairment to normal or near-normal cognition: Risk factors and prognosis G Rosenberg Neurology 80 (19), 1818-1818, 2013 | 2 | 2013 |
| DP-VPA Antiepileptic Drug G Rosenberg, JE Friedman, I Shapiro, A Kozak Drugs of the Future 30 (12), 1212-1218, 2005 | 2* | 2005 |
| Letter re: Calcium supplementation and risk of dementia in women with cerebrovascular disease DJ Beale Neurology 88 (8), 812-812, 2017 | 1 | 2017 |
| Erratum: A novel phospholipid derivative of indomethacin, DP-155 [mixture of 1-steroyl and 1-palmitoyl-2-{4-[1-(p-chlorobenzoyl)-5-methoxy-2-methyl-3-indolyl acetamido … E Dvir, JE Friedman, JY Lee, JY Koh, F Younis, S Raz, I Shapiro, ... Journal of Pharmacology and Experimental Therapeutics 319 (3), 1492, 2006 | 1 | 2006 |
